Transcriptome sequencing reveals PCAT5 as a Novel ERG-Regulated long Noncoding RNA in prostate cancer

Cancer Research

Volumn 75, Issue 19, 2015, Pages 4026-4031

  Ylipää, Antti ^a   Kivinummi, Kati ^a   Kohvakka, Annika ^a,b   Annala, Matti ^a   Latonen, Leena ^a,b   Scaravilli, Mauro ^a,b   Kartasalo, Kimmo ^a   Leppänen, Simo Pekka ^a   Karakurt, Serdar ^a,b   Seppäla, Janne ^a   Yli Harja, Olli ^a   Tammela, Teuvo L J ^b   Zhang, Wei ^c   Visakorpi, Tapio ^a,b   Nykter, Matti ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; RNA; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTOME; ERG PROTEIN, HUMAN; MESSENGER RNA; TRANSACTIVATOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RECURRENCE; CASTRATION RESISTANT PROSTATE CANCER; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RNA TRANSCRIPTION; TRANSURETHRAL RESECTION; ADENOCARCINOMA; AGED; BIOSYNTHESIS; CELL MOTION; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROSTATE HYPERTROPHY; TUMOR CELL LINE; TUMOR INVASION;

ADENOCARCINOMA; AGED; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PHENOTYPE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; RNA, LONG NONCODING; RNA, MESSENGER; RNA, NEOPLASM; TRANS-ACTIVATORS; TRANSCRIPTOME;

EID: 84945395861     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-0217     Document Type: Article

References (19)

1. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005;310:644-8.
2. Yu J, Yu J, Mani RS, Cao Q, BrennerCJ, Cao X, et al. An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell 2010;17:443-54.
3. Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 2007;448: 595-9.
4. Annala M, Kivinummi K, Tuominen J, Karakurt S, Granberg K, Latonen L, et al. Recurrent SKIL-Activating rearrangements in ETS negative prostate cancer. Oncotarget 2015;6:6235-50.
5. Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov 2011;1:391-407.
6. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007;129:1311-23.
7. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell 2011;43:904-14.
8. Srikantan V, Zou Z, Petrovics G, Xu L, Augustus M, Davis L, et al.PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc Natl Acad Sci U S A 2000;97:12216-21.
9. Chung S, Nakagawa H, Uemura M, Piao L, Ashikawa K, Hosono N, et al. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci 2011;102:245-52.
10. Prensner JR, Iyer MK, Balbin OA, Dhanasekaran SM, Cao Q, Brenner JC, et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol 2011;29:742-9.
11. Prensner JR, Iyer MK, Sahu A, Asangani IA, Cao Q, Patel L, et al. The long noncoding RNA SchLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat Genet 2013;45:1392-8.
12. Prensner JR, Chen W, Iyer MK, Cao Q, Ma T, Han S, et al. PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer. Cancer Res 2014;74:1651-60.
13. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010;28:511-5.
14. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 2011;24:1915-27.
15. ENCODE Project Consortium Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57-74.
16. Kannan K, Wang L, Wang J, Ittmann MM, Li W, Yen L. Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing. Proc Natl Acad Sci U S A 2011;108:9172-7.
17. Bu D, Yu K, Sun S, Xie C, Skogerbø G, Miao R, et al. NONCODE v3.0: integrative annotation of long noncoding RNAs. Nucleic Acids Res 2012;40:D210-5.
18. Hessels D, Schalken JA. The use of PCA3 in the diagnosis of prostate cancer. Nat Rev Urol 2009;6:255-61.
19. Li CH, Chen Y. Targeting long non-coding RNAs in cancers: progress and prospects. Int J Biochem Cell Biol 2013;45:1895-910.